Health ❯ Healthcare ❯ Diseases

Respiratory Diseases

Pneumonia Bronchiolitis Chronic Obstructive Pulmonary Disease Bronchiectasis Respiratory Syncytial Virus Acute Respiratory Distress Syndrome Influenza Pulmonary Fibrosis Respiratory Syncytial Virus (RSV) RSV (Respiratory Syncytial Virus) Infections Acute Respiratory Infections Cold and COVID-19 Idiopathic Pulmonary Fibrosis Walking Pneumonia Pulmonary Sarcoidosis Bronchitis Atemwegsinfekte COVID-19 Community-Acquired Pneumonia Covid-19 Variants Chronic Obstructive Pulmonary Disease (COPD) Lung Fibrosis Tuberculosis Mycobacterium Avium Complex (MAC) Lung Disease Common Cold Asthma Pulmonary Alveolar Proteinosis Severe Acute Respiratory Syndrome (SRAG) Sinusitis

aTyr Pharma Secures FDA Agreement on Phase 3 Protocol for Efzofitimod in Pulmonary Sarcoidosis

FDA alignment lets the company plan a 54-week, 372-patient global trial beginning in Q4 2026 that will measure lung function at week 48.

EMA Recommends Jascayd for Two Progressive Lung Fibrosis Conditions

Northwestern Reports Flow‑Adaptive Total Artificial Lung That Bridged a 48‑Hour Transplant Window

Swedish Study Finds Healthy Newborns at High Risk of Severe RSV, Spurring Expanded Protections

Inpatient COPD Care Pathway Tied to Shorter Stays and More Pulmonary Rehab Referrals

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis